Microbial Fermentation Technology Market Trends

  • Report ID: 5329
  • Published Date: Oct 18, 2023
  • Report Format: PDF, PPT

Microbial Fermentation Technology Market Trends

Growth Drivers

  • Rising Need for Fermented Food – Fermentation of food is done by regulating microbial development, which involves microorganisms such as yeast and bacteria enzymatically breaking down carbohydrates to produce carbon dioxide, organic acids, or alcohol, and the process also contributes to food sustainability by preserving, securing, and producing food components.
  • Increasing Popularity of CRISPR-Cas9 Technology- CRISPR-Cas9 technology transforms bacteria to boost target product yield and is capable of expanding the range of compounds and products available through fermentation.
  • Growing Adoption of Artificial Intelligence and Machine Learning- AI technology is extremely significant in the development of precision fermentation which is based on the use of microbes – mainly yeasts and fungi and may also assist in developing unique food products that meet the growing customer demand for natural, functional, and sustainable food options.

Additionally, Artificial intelligence is now being utilized to control fermentation operations in real time, and it can analyze past data to forecast future outcomes.

  • Spiking Cases of Infectious Diseases- This may lead to higher production of vaccines and antiviral drugs which are produced using microbial fermentation technology.
  • Rising Need for Gasoline- This has led to an increase in the production of biofuels such as ethanol and butanol which are produced by microbial fermentation that converts sugars derived from lignocellulosic biomass.
  • Growing Production of Biosimilars- Biosimilars are produced using are produced by living cells such as bacteria or yeast and are often produced by advanced fermentation technology.
  • Higher Usage of Single-Use Bioreactor Systems- Single-use bioreactor Systems (SUB Disposable) can be used for microbial fermentation as they reduce the risk of cross-contamination which helps in meeting the stringent regulations of the pharmaceutical industry.

Challenges

  • High Cost of Microbial Fermentation Technology – The research & development for developing a new fermentation process involves a huge cost as it requires skilled labor, high-quality raw materials, and energy-intensive equipment. This may make it difficult for pharmaceutical companies with limited budgets to carry out these processes. Furthermore, setting up a fermentation plant, which includes the cost of labor and other costs incurred to maintain the facility, can easily cost tens to hundreds of millions of dollars.
  • Stringent Regularity Requirements for Biopharmaceutical Production
  • Risk of Microbial Contamination Leading to Product Loss

Microbial Fermentation Technology Market: Key Insights

Base Year

2023

Forecast Year

2024-2036

CAGR

~6%

Base Year Market Size (2023)

~ USD 33 Billion

Forecast Year Market Size (2036)

~ USD 63 Billion

Regional Scope

  • North America (U.S., and Canada)
  • Latin America (Mexico, Argentina, Rest of Latin America)
  • Asia-Pacific (Japan, China, India, Indonesia, Malaysia, Australia, Rest of Asia-Pacific)
  • Europe (U.K., Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Gupta, Shivam Bhutani


  • Report ID: 5329
  • Published Date: Oct 18, 2023
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

The rising need for vaccines and the growing need for microbial contract manufacturing services are the major factors driving the growth of the market.

The market size of Microbial Fermentation Technology is anticipated to attain a CAGR of 6% over the forecast period, i.e., 2024-2036.

The major players in the market are BioVectra Inc., Danone UK, F. Hoffmann-La Roche AG, Koninklijke DSM NV, Lonza, Novozymes A/S, TerraVia Holdings, Inc., BIOZEEN

The antibiotics segment is anticipated to garner the largest market size by the end of 2036 and display significant growth opportunities.

The market in the Asia Pacific region is projected to hold the largest market share by the end of 2036 and provide more business opportunities in the future.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying